Search results for "Nocturnal"

showing 10 items of 86 documents

Development Of a Disease Specific Quality Of Life Questionnaire For Patients With Aplastic Anemia and/Or Paroxysmal Nocturnal Hemoglobinuria (QLQ-AA/…

2013

Abstract Introduction Acquired Aplastic Anemia (AA) and Paroxysmal Nocturnal Hemoglobinuria (PNH) are ultra-rare diseases with a yearly incidence 2 to 4 per million (AA) and of 1.3 to 2 per million (PNH. While much is known about pathophysiology and treatment of these interrelated diseases, less is known about patients (pts.) psycho-social issues. Quality of life (QoL) evaluation tools used in all studies for AA and PNH are rather unspecific and were initially designed for cancer patients (e.g. the European Organization of Research and Treatment (EORTC) QLQ-C30). Given the complexity of AA and PNH, the variation in symptoms and different treatment approaches (immunosuppression, bone marrow …

Pediatricsmedicine.medical_specialtybusiness.industryIncidence (epidemiology)ImmunologyCell BiologyHematologymedicine.diseaseBiochemistryFocus grouphumanitiesQuality of lifeHealth careParoxysmal nocturnal hemoglobinuriaMedicineAplastic anemiabusinessPsychosocialDisease burdenBlood
researchProduct

Effects of brofaremine (CGP 11 305A), a short-acting, reversible, and selective inhibitor of MAO-A on sleep, nocturnal penile tumescence and nocturna…

1987

The effects of brofaremine (CGP 11 305A), a short-acting, reversible and selective inhibitor of MAO-A, on sleep, nocturnal penile tumescence (NPT) and hormonal secretion during the night were studied during a long-term trial. Three healthy males underwent sleep-EEG and NPT recordings during consecutive nights (1) under placebo, (2) under stepwise increasing dosages of brofaremine and (3) under placebo after withdrawal. Hormone profiles were sampled during selected nights to analyze the plasma concentration of cortisol, HGH, prolactin, testosterone, LH and FSH. REM sleep was suppressed markedly under 150 mg brofaremine, while stages 1 and 2 increased. In comparison to the effect of irreversi…

PharmacologyAdultMalemedicine.medical_specialtyMonoamine Oxidase Inhibitorsbusiness.industryPenile ErectionSleep REMElectroencephalographyNocturnalPlaceboSleep in non-human animalsREM reboundProlactinHormonesEndocrinologyPiperidinesInternal medicineNocturnal penile tumescencemedicineHumansbusinessSleepTestosteroneHormonePsychopharmacology
researchProduct

Thrombotic risk in paroxysmal nocturnal hemoglobinuria-like (PNH-like) phenotype

2020

The complement system is an essential component of the innate immune defence that, if overly activated, may damage organs and tissues. For this reason, there is a fine complement regulatory system. The complement modulation system includes two proteins with important regulatory activity, CD55 or decay accelerating factor (DAF) and CD59 or membrane inhibitor of reactive lysis (MIRL). The paroxysmal nocturnal hemoglobinuria (PNH) is a clonal and non-neoplastic disease characterized by intravascular haemolysis, occurrence of thrombosis and bone marrow failure. In clinical practice, in opposition to PNH, a variety of pathological conditions have been observed with an acquired and non-genetic de…

PhysiologyHemoglobinuria ParoxysmalDiseaseCD59030204 cardiovascular system & hematologyHemolysis030218 nuclear medicine & medical imagingSettore MED/15 - Malattie Del Sangue03 medical and health sciences0302 clinical medicinehemic and lymphatic diseasesPhysiology (medical)medicineHumansParoxysmal nocturnal hemoglobinuriaDecay-accelerating factorcomplement systemInnate immune systembusiness.industryThrombosisHematologythromboembolic riskmedicine.diseasePhenotypeComplement systemPhenotypemedicine.anatomical_structureImmunologyParoxysmal nocturnal hemoglobinuriaBone marrowCD55Cardiology and Cardiovascular MedicinebusinessCD59
researchProduct

The Acute Effect of Low Intensity Aerobic Exercise on Psychomotor Performance of Athletes with Nocturnal Sleep Deprivation

2018

Objectives: Psychomotor performance is a vital factor which decisively affects the athletic performance. The purpose of the research was to investigate the acute effects of low intensity aerobic exercise on psychomotor performance of athletes with nocturnal sleep deprivation. Methods: Sixteen professional female volleyball players with mean age of 22.3 ± 2.6 years old were studied twice in a balanced, randomized design. The participants were asked to fill the Pittsburgh sleep quality index (PSQI) prior to the beginning of the study and their nocturnal activity was recorded at 1-minute intervals and scored with the Actiwatch sleep analysis. The study used the Vienna Test System to measure co…

Psychomotor learningmedicine.medical_specialtybiologyAthletesbusiness.industryCognition030229 sport sciencesNocturnalbiology.organism_classificationPittsburgh Sleep Quality Index03 medical and health sciencesSleep deprivation0302 clinical medicinePhysical therapymedicineAerobic exercisemedicine.symptombusiness030217 neurology & neurosurgeryCompletely randomized designInternational journal of Sport Studies for Health
researchProduct

Prevalence of nocturnal asthma in a general population sample: determinants and effect of aging.

2000

Nocturnal asthma (NA) is important because of clinical and prognostic implications. Previous data on prevalence may be overestimated, because they are derived from selected series. Observations on monitoring of peak expiratory flow in elderly asthmatics suggested that prevalence of NA may increase with age. This study was designed to estimate the prevalence of NA-related symptoms in a sample drawn from a general population and evaluate the role of aging. Subjects (1,100, mean age 41.9, SD 22.8 years) were randomly selected from the lists of seven general practitioners. A questionnaire on nighttime and morning NA-associated symptoms was used and frequency of occurrence was rated as never, so…

Pulmonary and Respiratory MedicineAdultMaleSampling StudiePediatricsmedicine.medical_specialtyAgingRandomizationLogistic ModelPopulation samplePopulationPeak Expiratory Flow RateSettore MED/10 - Malattie Dell'Apparato RespiratorioLogistic regressionSampling StudiesRandom AllocationRisk FactorsSurveys and QuestionnairesEpidemiologymedicinePrevalenceSurveys and QuestionnaireImmunology and AllergyHumanseducationSicilyAsthmaMorningeducation.field_of_studybusiness.industryRisk Factormedicine.diseaseAsthmaCircadian RhythmLogistic ModelsPediatrics Perinatology and Child HealthNocturnal asthmaFemaleBronchial HyperreactivitybusinessHumanThe Journal of asthma : official journal of the Association for the Care of Asthma
researchProduct

Reticulocytes in untreated obstructive sleep apnoea.

2008

Background and Aim. The short, repetitive hypoxaemic episodes observed in obstructive sleep apnoea (OSA) may determine small augmentations in mature red blood cells. It is unknown whether they affect reticulocyte release. This study explored whether the number and degree of maturation of circulating reticulocytes may be altered in OSA, possibly through the effect of erythropoietin. Methods. Fifty male adult patients with suspected OSA, normoxic during wakefulness, were studied. After nocturnal polysomnography, a blood sample was withdrawn for blood cells count, erythropoietin, iron and transferrin determination. Reticulocyte concentration and degree of immaturity [high (H), medium (M), or l…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyPolysomnographylcsh:MedicineSettore MED/10 - Malattie Dell'Apparato RespiratorioSeverity of Illness IndexHaematopoiesis Nocturnal hypoxemia Obstructive sleep apnoea ErythropoietinCohort StudiesReticulocyteReticulocyte CountInternal medicinemedicineHumansErythropoiesisErythropoietinOxygen saturation (medicine)chemistry.chemical_classificationUnivariate analysisSleep Apnea ObstructiveTransferrin saturationbusiness.industryNocturnal hypoxemialcsh:RTransferrinMiddle Agedrespiratory tract diseasesHaematopoiesisEndocrinologymedicine.anatomical_structureHaematopoiesischemistryErythropoietinTransferrinObstructive sleep apnoeaWakefulnessCardiology and Cardiovascular Medicinebusinessmedicine.drug
researchProduct

Usefulness of transcutaneous PCO2to assess nocturnal hypoventilation in restrictive lung disorders

2016

Background and objectiveNocturnal hypoventilation is now an accepted indication for the initiation of non-invasive ventilation. Nocturnal hypoventilation may be an under diagnosed condition in chronic respiratory failure. The most appropriate strategy to identify sleep hypoventilation is not yet clearly defined. In clinical practice, it is indirectly assessed using nocturnal pulse oximetry (NPO) and morning arterial blood gases (mABG). Even though continuous transcutaneous carbon dioxide partial pressure (TcPCO2) monitoring is theoretically superior to NPO plus mABG, it is not routinely used. We aimed to prospectively compare NPO plus mABG with nocturnal TcPCO2 for the detection of alveolar…

Pulmonary and Respiratory MedicineMechanical ventilationmedicine.diagnostic_testbusiness.industrymedicine.medical_treatmentNocturnalHypoxia (medical)Hypoventilation03 medical and health sciencesPulse oximetry0302 clinical medicine030228 respiratory systemRespiratory failureAnesthesiamedicineArterial bloodmedicine.symptombusinessHypercapnia030217 neurology & neurosurgeryRespirology
researchProduct

Long-Term Oxygen Therapy

1994

Pulmonary and Respiratory Medicinebusiness.industryAnesthesiaLong-term oxygen therapyMedicineLiterNocturnalCardiology and Cardiovascular MedicineCritical Care and Intensive Care MedicinebusinessChest
researchProduct

Chronic kidney disease in patients with obstructive sleep apnea. A narrative review.

2018

Prevalence of both chronic kidney disease (CKD) and obstructive sleep apnea (OSA) is continuously increasing. Moreover, the prevalence of OSA increases as kidney function declines and is higher among patients with end-stage renal disease (ESRD). In addition, OSA is recognized as a potential nontraditional risk factor for development and progression of CKD. Continuous positive airway pressure (CPAP) plays a pivotal role in the management of OSA, eliminating patients' symptoms and improving their quality of life. Recent studies suggested that CPAP treatment may have beneficial effects on kidney function among patients with OSA. This narrative review summarizes the existing knowledge on the as…

Pulmonary and Respiratory Medicinemedicine.medical_specialtymedicine.medical_treatmentRenal functionDiseaseSettore MED/10 - Malattie Dell'Apparato Respiratoriourologic and male genital diseases03 medical and health sciences0302 clinical medicinestomatognathic systemQuality of lifeRisk FactorsPhysiology (medical)Internal medicineEpidemiologymedicineHumansContinuous positive airway pressureRisk factorRenal Insufficiency ChronicChronic kidney disease Continuous positive airway pressure Kidney function Nocturnal hypoxia Obstructive sleep apneaSleep Apnea ObstructiveContinuous Positive Airway Pressurebusiness.industrymedicine.diseasenervous system diseasesrespiratory tract diseasesObstructive sleep apnea030228 respiratory systemNeurologyNeurology (clinical)business030217 neurology & neurosurgeryKidney diseaseSleep medicine reviews
researchProduct

Direct measurement of NO3 radical reactivity in a boreal forest

2018

We present the first direct measurements of NO3 reactivity (or inverse lifetime, s−1) in the Finnish boreal forest. The data were obtained during the IBAIRN campaign (Influence of Biosphere-Atmosphere Interactions on the Reactive Nitrogen budget) which took place in Hyytiälä, Finland during the summer/autumn transition in September 2016. The NO3 reactivity was generally very high with a maximum value of 0.94 s−1 and displayed a strong diel variation with a campaign-averaged nighttime mean value of 0.11 s−1 compared to a daytime value of 0.04 s−1. The highest nighttime NO3 reactivity was accompanied by major depletion of canopy level ozone and was associated with strong temperature inversion…

SESQUITERPENE EMISSIONSBIOGENIC EMISSIONSOXIDATION CAPACITYSEASONAL-VARIATIONIN-SITU MEASUREMENTSRURAL MOUNTAIN-SITENOCTURNAL BOUNDARY-LAYERVOLATILE ORGANIC-COMPOUNDS114 Physical scienceslcsh:QC1-999lcsh:Chemistrylcsh:QD1-999SCOTS PINEATMOSPHERIC CHEMISTRY1172 Environmental scienceslcsh:PhysicsAtmospheric Chemistry and Physics
researchProduct